New pill for psoriasis shows early promise in small trial
NCT ID NCT05453942
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 24 times
Summary
This early-stage study tested an oral medication called SAR441566 in 38 adults with mild to moderate psoriasis. The goal was to check safety and see if the drug improves skin symptoms over 4 weeks compared to a placebo. Participants were randomly assigned to receive either the drug or a placebo, and researchers tracked side effects and changes in skin lesion severity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number :2760001
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.